These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17641237)

  • 1. Thrombolytic therapy for acute ischemic stroke: the likelihood of being helped versus harmed.
    Demaerschalk BM
    Stroke; 2007 Aug; 38(8):2215-6. PubMed ID: 17641237
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of the stroke code activation source on the outcome of acute ischemic stroke patients.
    Whitcomb DS
    Neurology; 2009 May; 72(19):1709; author reply 1710. PubMed ID: 19433750
    [No Abstract]   [Full Text] [Related]  

  • 3. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis--not a panacea for ischemic stroke.
    Caplan LR; Mohr JP; Kistler JP; Koroshetz W
    N Engl J Med; 1997 Oct; 337(18):1309-10; discussion 1313. PubMed ID: 9345084
    [No Abstract]   [Full Text] [Related]  

  • 4. Post-thrombolysis hemorrhage in a patient with hypothyroidism and acute ischemic stroke: Case report.
    Gu F; Qin J; Chen R; Xu X
    Neurol Neurochir Pol; 2015; 49(4):290-4. PubMed ID: 26188947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
    Schestatsky P; Picon PD
    Neurology; 2005 Dec; 65(11):1844; author reply 1844. PubMed ID: 16344546
    [No Abstract]   [Full Text] [Related]  

  • 6. Breaking the 3 h barrier for treatment of acute ischaemic stroke.
    Donnan GA; Davis SM
    Lancet Neurol; 2008 Nov; 7(11):981-2. PubMed ID: 18940690
    [No Abstract]   [Full Text] [Related]  

  • 7. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
    Kleindorfer DO; Khatri P; Katzan I
    Neurology; 2005 Dec; 65(11):1844; author reply 1844. PubMed ID: 16353320
    [No Abstract]   [Full Text] [Related]  

  • 8. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? t-PA--the best current option for most patients.
    Grotta J
    N Engl J Med; 1997 Oct; 337(18):1310-3. PubMed ID: 9345085
    [No Abstract]   [Full Text] [Related]  

  • 9. SITS-MOST: old myths laid to rest.
    Hallevi H; Grotta JC
    Lancet Neurol; 2007 Apr; 6(4):292-3. PubMed ID: 17362829
    [No Abstract]   [Full Text] [Related]  

  • 10. The smoking-thrombolysis paradox and acute ischemic stroke.
    Fisher M
    Neurology; 2006 Feb; 66(3):458; author reply 458. PubMed ID: 16476964
    [No Abstract]   [Full Text] [Related]  

  • 11. Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke.
    Prabhakaran S; Rivolta J; Vieira JR; Rincon F; Stillman J; Marshall RS; Chong JY
    Arch Neurol; 2010 May; 67(5):559-63. PubMed ID: 20212195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THRIVE score predicts ischemic stroke outcomes and thrombolytic hemorrhage risk in VISTA.
    Flint AC; Faigeles BS; Cullen SP; Kamel H; Rao VA; Gupta R; Smith WS; Bath PM; Donnan GA;
    Stroke; 2013 Dec; 44(12):3365-9. PubMed ID: 24072004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TPA within 3 hours of acute ischaemic stroke?
    Dorman P; Sandercock P
    Lancet; 1996 Dec; 348(9042):1600-1. PubMed ID: 8961984
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombolysis for stroke: defining the time window.
    Davis SM; Donnan GA
    Stroke; 2002 Feb; 33(2):495-6. PubMed ID: 12532952
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute neurovascular syndromes: hurry up, please, it's time.
    Kennedy J; Buchan AM
    Stroke; 2004 Feb; 35(2):360-2. PubMed ID: 14757879
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombolysis in acute ischemic stroke with vitreous hemorrhage.
    Moudgil SS
    Arch Neurol; 2009 Sep; 66(9):1178; author reply 1178-9. PubMed ID: 19752314
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does dementia increase risk of thrombolysis?: a case-control study.
    Alshekhlee A; Li CC; Chuang SY; Vora N; Edgell RC; Kitchener JM; Kale SP; Feen E; Piriyawat P; Callison RC; Cruz-Flores S
    Neurology; 2011 May; 76(18):1575-80. PubMed ID: 21451151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fatal massive hemoptysis during thrombolysis of acute ischemic stroke].
    de la Torre-Laviana FJ; Redondo L; Antunez-Infante A; Alvarez-Marquez E
    Rev Neurol; 2006 Oct 16-31; 43(8):510-1. PubMed ID: 17033985
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: a Cleveland update.
    Katzan IL; Hammer MD; Furlan AJ; Hixson ED; Nadzam DM;
    Stroke; 2003 Mar; 34(3):799-800. PubMed ID: 12624312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.